Quidelortho Corp (QDEL) Stock Price, Quote & News

Company Profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, ant...

Industry: Medical Devices

Sector: Healthcare

Phone: 858 552 1100

Fax: 858 453 4338

Website: www.quidelortho.com

Address:

9975 Summers Ridge Road, San Diego, United States

AdamInvest Aug. 4 at 4:48 PM

$QDEL

0 · Reply

PencilNeckGeek Jul. 31 at 3:24 PM

$QDEL wow this one has collapsed. What a turd. Not a positive sign heading into earnings

0 · Reply

Estimize Jul. 31 at 1:06 PM

Wall St is expecting 0.00 EPS for $QDEL Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co

0 · Reply

AdamInvest Jul. 31 at 1:57 AM

$QDEL my homie been laying people off it’s gunna keep dumping 🤷🏼‍♂️

0 · Reply

Estimize Jul. 24 at 1:06 PM

Wall St is expecting 0.00 EPS for $QDEL Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co

0 · Reply

gvnbykplt1903 Jul. 19 at 2:24 AM

$QDEL

0 · Reply

Tryingnottolosemyarse Jul. 18 at 8:14 PM

$QDEL oversold!!!!!

0 · Reply

PencilNeckGeek Jul. 18 at 1:52 PM

$QDEL what happened to this? It's acting like a POS but I'm buying for a swing

0 · Reply

BuysSells Jul. 17 at 6:17 PM

$QDEL FFS, what a turd! Buying more here.....

0 · Reply

PencilNeckGeek Jul. 17 at 5:54 PM

$QDEL bought some shares here.

0 · Reply

QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™

Jul 24, 2025, 9:00 AM EDT - 12 days ago

Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast

Jul 22, 2025, 4:30 PM EDT - 13 days ago

QuidelOrtho to Report Second Quarter 2025 Financial Results

Jul 17, 2025, 7:00 AM EDT - 19 days ago

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

Jul 14, 2025, 7:00 AM EDT - 22 days ago

QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA)

Jul 7, 2025, 7:00 AM EDT - 4 weeks ago

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

Jun 3, 2025, 4:10 PM EDT - 2 months ago

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

May 22, 2025, 4:30 PM EDT - 2 months ago

QuidelOrtho to Participate in Upcoming Investor Conferences

May 12, 2025, 9:30 AM EDT - 3 months ago

QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)

May 7, 2025, 7:56 PM EDT - 3 months ago

QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 3 months ago

QuidelOrtho Reports First Quarter 2025 Financial Results

Apr 23, 2025, 4:30 PM EDT - 3 months ago

QuidelOrtho to Report First Quarter 2025 Financial Results

Mar 10, 2025, 9:00 AM EDT - 5 months ago

QuidelOrtho® Introduces Results Manager™ System

Feb 24, 2025, 7:00 AM EST - 5 months ago

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

Feb 12, 2025, 7:50 PM EST - 6 months ago

QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 4:05 PM EST - 6 months ago

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

Jan 13, 2025, 9:00 AM EST - 7 months ago

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

Jan 7, 2025, 12:48 AM EST - 7 months ago

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

Dec 31, 2024, 7:00 AM EST - 7 months ago

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 10, 2024, 7:00 AM EST - 8 months ago

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Nov 20, 2024, 3:08 PM EST - 9 months ago

Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted

Nov 20, 2024, 8:06 AM EST - 9 months ago

Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

TGT POWL

Nov 19, 2024, 9:05 PM EST - 9 months ago

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

Nov 19, 2024, 4:54 PM EST - 9 months ago

QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group

Nov 11, 2024, 6:18 AM EST - 9 months ago

Top 4 Health Care Stocks That May Plunge This Quarter

AIRS NUVB PODD

Nov 7, 2024, 8:54 PM EST - 9 months ago

QuidelOrtho Corporation (QDEL) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 9 months ago

QuidelOrtho Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 7:00 AM EDT - 10 months ago

QuidelOrtho to Participate in Three Upcoming Investor Conferences

Oct 17, 2024, 7:00 AM EDT - 10 months ago

QuidelOrtho to Report Third Quarter 2024 Financial Results

Oct 9, 2024, 7:00 AM EDT - 10 months ago

QuidelOrtho Announces New R&D Executive Leader

Sep 10, 2024, 7:00 AM EDT - 11 months ago

QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer

Aug 29, 2024, 7:00 AM EDT - 1 year ago

VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.

Jul 31, 2024, 9:02 PM EDT - 1 year ago

QuidelOrtho Corporation (QDEL) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 1 year ago

QuidelOrtho Reports Second Quarter 2024 Financial Results

Jul 23, 2024, 7:17 PM EDT - 1 year ago

Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600

APO AVTR HIBB SNDR SPGI

Jul 17, 2024, 7:00 AM EDT - 1 year ago

QuidelOrtho to Report Second Quarter 2024 Financial Results

Jun 11, 2024, 4:00 PM EDT - 1 year ago

The Schall Law Firm Encourages Investors Who Have Suffered Losses In QuidelOrtho Corporation To Make Contact

Jun 11, 2024, 10:30 AM EDT - 1 year ago

DEADLINE TODAY: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

Jun 10, 2024, 3:44 PM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of QuidelOrtho

Jun 10, 2024, 10:50 AM EDT - 1 year ago

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

Jun 9, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors Who Have Experienced Losses In QuidelOrtho Corporation To Get In Touch

Jun 8, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Encourages Investors Who Have Suffered Losses in QuidelOrtho Corporation to Make Contact

Jun 6, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors With Losses In QuidelOrtho Corporation To Reach Out

Jun 5, 2024, 7:30 PM EDT - 1 year ago

QuidelOrtho (QDEL) Investors Who Suffered Substantial Losses After QDEL Reported Disastrous Q4 2023 Results, Terminated CEO, & Withdrew FDA Submission Should Contact Hagens Berman Before June 11, 2024 Deadline

Jun 4, 2024, 11:00 AM EDT - 1 year ago

QDEL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

Jun 2, 2024, 11:00 AM EDT - 1 year ago

CRUCIAL DEADLINE REMINDER: The Schall Law Firm Encourages Investors in QuidelOrtho Corporation with Losses to Contact the Firm

AdamInvest Aug. 4 at 4:48 PM

$QDEL

0 · Reply

PencilNeckGeek Jul. 31 at 3:24 PM

$QDEL wow this one has collapsed. What a turd. Not a positive sign heading into earnings

0 · Reply

Estimize Jul. 31 at 1:06 PM

Wall St is expecting 0.00 EPS for $QDEL Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co

0 · Reply

AdamInvest Jul. 31 at 1:57 AM

$QDEL my homie been laying people off it’s gunna keep dumping 🤷🏼‍♂️

0 · Reply

Estimize Jul. 24 at 1:06 PM

Wall St is expecting 0.00 EPS for $QDEL Q2 [Reporting 08/05 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co

0 · Reply

gvnbykplt1903 Jul. 19 at 2:24 AM

$QDEL

0 · Reply

Tryingnottolosemyarse Jul. 18 at 8:14 PM

$QDEL oversold!!!!!

0 · Reply

PencilNeckGeek Jul. 18 at 1:52 PM

$QDEL what happened to this? It's acting like a POS but I'm buying for a swing

0 · Reply

BuysSells Jul. 17 at 6:17 PM

$QDEL FFS, what a turd! Buying more here.....

0 · Reply

PencilNeckGeek Jul. 17 at 5:54 PM

$QDEL bought some shares here.

0 · Reply

Staska Jul. 14 at 3:30 PM

$QDEL https://www.prnewswire.com/news-releases/quidelortho-and-buhlmann-laboratories-ag-announce-availability-of-fecal-calprotectin-fcal-turbo-and-fecal-pancreatic-elastase-fpela-turbo-assays-on-vitros-systems-as-a-microtip-partnership-assay-mpa-302503588.html

0 · Reply

Staska Jul. 8 at 5:25 PM

$QDEL When Australia has a big flu season US has it too. Last year was the case. https://www.abc.net.au/news/2025-07-04/flu-cases-and-hospitalisations-rising-in-south-australia/105494384

0 · Reply

unmun3114 Jul. 7 at 7:40 PM

Does anyone know why Anbio Biotechnology ($NNNN) isn't listed on Stocktwits? The company went public in February and competes with $QDEL

1 · Reply

StockBraker Jul. 3 at 12:45 PM

$QDEL https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-quidelortho-qdel-blurbs

0 · Reply

JarvisFlow Jul. 2 at 12:00 PM

UBS updates rating for QuidelOrtho ( $QDEL ) to Neutral, target set at 50 → 43.

0 · Reply

smartkarma Jun. 25 at 5:04 AM

$QDEL | QuidelOrtho Corporation Is Executing A Billion-Dollar Manufacturing Overhaul; What Is The Expected Revenue Impact? "QuidelOrtho's latest earnings provides insight into the company's performance and strategic direction. For the first quarter of 2025, QuidelOrtho..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/quidelortho-corporation-is-executing-a-billion-dollar-manufacturing-overhaul-what-is-the-expected-revenue-impact

0 · Reply

ZacksResearch Jun. 24 at 4:39 PM

$QDEL: After a 37.9% YTD drop, is this diagnostic company poised for a comeback? 📈 🩺 Strong Q1 results driven by Labs, Immunohematology, and Molecular Diagnostics segments 🧬 Expanding product portfolio, including FDA-approved Savanna system 📊 Positive earnings estimate revision trend for 2025, despite risks from overdependence on respiratory segment and reimbursement policies Discover the full growth potential here 👉 https://www.zacks.com/commentary/2545042/reasons-to-retain-quidelortho-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2545042-body&ADID=SYND_STOCKTWITS_TWEET_2_2545042_BODY

0 · Reply

ZacksResearch Jun. 24 at 2:55 PM

$QDEL — Why I’m holding, not folding The company’s solid product lineup is still driving growth, giving it staying power in this market. Full breakdown on why QDEL still earns a spot in the portfolio 👉 https://www.zacks.com/stock/news/2545042/reasons-to-retain-quidelortho-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2545042-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2545042_TEASER

0 · Reply

yurched Jun. 13 at 11:00 AM

$QDEL 💀 DEBT BOMB

0 · Reply

StockBraker Jun. 9 at 12:18 PM

$QDEL 6-10 minute testing using patented thermal cycling technology.

0 · Reply

OpenOutcrier Jun. 4 at 11:45 AM

$QDEL (-4.3% pre) QuidelOrtho Makes Major Molecular Diagnostics Pivot: $100M LEX Acquisition to Replace Savanna Platform https://ooc.bz/l/66835

0 · Reply

DonCorleone77 Jun. 3 at 8:19 PM

$QDEL QuidelOrtho maintains FY25 guidance issued on February 12 Based on its current business outlook, the company is maintaining its fiscal 2025 financial guidance provided on February 12, 2025.

0 · Reply

Market Cap	1.54B
Revenue (ttm)	2.78B
Net Income (ttm)	-2.05B
EPS (ttm)	N/A
PE Ratio	10.71
Forward PE	9.65
Profit Margin	-73.74%
Debt to Equity Ratio	0.83

Volume	847,697
Avg Vol	1,480,908
Day's Range	N/A - N/A
Shares Out	67.63M
Stochastic %K	38%
Beta	-0.03
Analysts	Sell
Price Target	$47.14